Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Ionis Pharmaceuticals Inc shares valued at $194,939 were sold by O’NEIL PATRICK R. on Feb 04 ’25. At $31.62 per share, O’NEIL PATRICK R. sold 6,165 shares. The insider’s holdings dropped to 57,452 shares worth approximately $1.74 million following the completion of this transaction.
Also, Monia Brett P sold 38,843 shares, netting a total of over 1,229,463 in proceeds. Following the sale of shares at $31.65 each, the insider now holds 180,683 shares.
Before that, Monia Brett P had added 40,003 shares to its account. In a trade valued at $1,285,296, the Officer bought Ionis Pharmaceuticals Inc shares for $32.13 each.
As published in a research note from BMO Capital Markets on August 02, 2024, Ionis Pharmaceuticals Inc [IONS] has been rated down from an Outperform to a Market perform and the price target has been revised to $60 from $67. Analysts at Leerink Partners upgraded the stock from ‘”a Market perform”‘ to ‘”an Outperform”‘ outlook in a report released in late July. Earlier on June 14, 2024, Bernstein upgraded its rating. Their new recommendation was “a Mkt perform” for IONS stock which previously was a “an Underperform”.
Analyzing IONS Stock Performance
During the last five days, there has been a drop of approximately -6.99%. Over the course of the year, Ionis Pharmaceuticals Inc shares have dropped approximately -13.19%. Shares of the company reached a 52-week high of $35.47 on 01/02/25 and a 52-week low of $30.23 on 02/13/25. A 50-day SMA is recorded $34.54, while a 200-day SMA reached $40.34. Nevertheless, trading volume fell to 1.49 million shares from 1.23 million shares the previous day.
Support And Resistance Levels for Ionis Pharmaceuticals Inc (IONS)
According to the 24-hour chart, there is a support level at 30.07, which, if violated, would cause prices to drop to 29.79. In the upper region, resistance lies at 30.79. The next price resistance is at 31.23. RSI (Relative Strength Index) is 36.14 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.33, which suggests the price will decrease in the coming days. Percent R is at 97.64%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
